CTNM EV/EBITDA

EV/EBITDA

-4.19
+0.16+3.68%

Wed, 26 Feb 2025 21:00:11 GMT


Summary


Performance

CTNM EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherCTNMvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CTNM EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+3.7%-3.5%-2.8%
1 m1 month+40.1%-40.1%-34.5%
3 m3 months+57.8%-57.8%-51.8%
6 m6 months+69.6%-65.8%-63.1%
ytdytd+56.0%-56.0%-50.0%
1 y1 year---
5 y5 years---

CTNM EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-2.4%-7.00+40.1%
3 m3-month-4.09-2.4%-9.93+57.8%
6 m6-month-4.09-2.4%-13.79+69.6%
1 y1-year27.66-115.2%-15.32+72.7%
3 y3-year27.66-115.2%-15.32+72.7%
5 y5-year27.66-115.2%-15.32+72.7%
alltimeall time27.66-115.2%-15.32+72.7%

Contineum Therapeutics Class A EV/EBITDA History

DateValue
2025
-4.19(-56.0%)
DateValue
2024
-9.53

FAQ

  • What is Contineum Therapeutics Class A EV/EBITDA?
  • What is the all time high EV/EBITDA for Contineum Therapeutics Class A?
  • What is CTNM EV/EBITDA year-to-date change?

What is Contineum Therapeutics Class A EV/EBITDA?

The current EV/EBITDA of CTNM is -4.19

What is the all time high EV/EBITDA for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high EV/EBITDA is 27.66

What is CTNM EV/EBITDA year-to-date change?

Contineum Therapeutics Class A EV/EBITDA has changed by +5.34 (+56.03%) since the beginning of the year